New guidelines for the treatment of tuberculosis

By Habeck M.  

The Lancet Infectious Diseases, Vol. 3, Iss. 5, 2003-05 ,pp. : 265-265

Elsevier

Access to resources Recommend Favorite

Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management

By Gardam M.A.   Keystone E.C.   Menzies R.   Manners S.   Skamene E.   Long R.   Vinh D.C.  

The Lancet Infectious Diseases, Vol. 3, Iss. 3, 2003-03 ,pp. : 148-155

Elsevier

Access to resources Recommend Favorite

The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 8, Iss. 2, 2013-08 ,pp. : 130-138

Bentham Science Publishers

Access to resources Recommend Favorite

HIV and tuberculosis coinfection: a qualitative study of treatment challenges faced by care providers

By Wannheden C.  

The International Journal of Tuberculosis and Lung Disease, Vol. 17, Iss. 8, 2013-08 ,pp. : 1029-1035

International Union Against Tuberculosis and Lung Disease

Access to resources Recommend Favorite

Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials

By Hartley A   Ho K F   McConkey C   Geh J I  

British Journal of Radiology, Vol. 78, Iss. 934, 2005-10 ,pp. : 934-938

British Institute of Radiology

Access to resources Recommend Favorite